Source:http://linkedlifedata.com/resource/pubmed/id/18652770
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2008-7-25
|
pubmed:abstractText |
We investigated the difference in survivin expression between a multidrug-resistant lung cancer cell line (H460/cDDP) and its parental counterpart (H460) and the influence of siRNA targeting survivin on the chemosensitivity of H460/cDDP. SiRNA targeting survivin was transfected into H460/cDDP cells using a liposome approach. Survivin mRNA and protein expression were significantly higher in H460/cDDP than H460 cells. The median inhibitory concentrations (IC(50)s) for cisplatin and paclitaxol in vitro against H460/cDDP cells were significantly lower in cells treated with survivin-specific siRNA than in control cells. Apoptosis and cleaved caspase-3 expression were analysed using annexin V and Western blotting, respectively, and showed a significant increase in apoptosis after treatment with the chemotherapeutic agents plus specific siRNA. Specific siRNA sensitized H460/cDDP cells to both cisplatin and paclitaxol. Thus, survivin appears to participate in the multidrug resistance mechanism of H460/cDDP cells and siRNA targeting survivin has the potential to increase the sensitivity of drug-resistant cancer cells to anticancer drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/BIRC5 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Apoptosis Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/Microtubule-Associated Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-0605
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
734-47
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18652770-Antineoplastic Agents,
pubmed-meshheading:18652770-Cell Line, Tumor,
pubmed-meshheading:18652770-Cisplatin,
pubmed-meshheading:18652770-Drug Resistance, Neoplasm,
pubmed-meshheading:18652770-Humans,
pubmed-meshheading:18652770-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:18652770-Liposomes,
pubmed-meshheading:18652770-Lung Neoplasms,
pubmed-meshheading:18652770-Microtubule-Associated Proteins,
pubmed-meshheading:18652770-Neoplasm Proteins,
pubmed-meshheading:18652770-Paclitaxel,
pubmed-meshheading:18652770-RNA, Small Interfering
|
pubmed:articleTitle |
Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells.
|
pubmed:affiliation |
Department of Thoracic Oncology, Cancer Centre, Sun Yat-Sen University, State Key Laboratory of Oncology in Southern China, Guangzhou, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|